Tissue-engineered heart valve scaffolds.

Since the first heterotopic implanted biological heart valve in 1956 by Murray, many improvements have been made. For allografts, different methods have been evaluated and modified to stabilize and preserve tissue. Xenografts were fixated to cross-link the connective tissue and to overcome immunogenic reactions. Nevertheless, glutaraldehyde fixation leads to structural deterioration, which can be partially reduced by different kinds of antimineralization treatments. Because of preservation and fixation, allografts and xenografts become nonviable bioprostheses with a lack of remodeling, regeneration, and growth. Tissue engineering is a possible key to overcome these disadvantages because it will provide a living tissue with remodeling, regeneration, and growth potential. This overview will issue the key points to provide such a tissue-engineered heart valve by creating a sufficient scaffold where cells can grow, either in vitro or in vivo, and remodel a neoscaffold that will lead to a functional autologous heart valve.

[1]  Alexander Lembcke,et al.  Ross operation with a tissue-engineered heart valve. , 2002, The Annals of thoracic surgery.

[2]  I. Yannas,et al.  Antigenicity and immunogenicity of collagen. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[3]  D. Ross,et al.  Pulmonary autograft procedure for aortic valve disease: long-term results of the pioneer series. , 1997, Circulation.

[4]  Wolfgang Konertz,et al.  Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep. , 2004, Artificial organs.

[5]  W. Chitwood,et al.  Video-assisted and robotic mitral valve surgery: toward an endoscopic surgery. , 1999, Seminars in thoracic and cardiovascular surgery.

[6]  R. Macleod,et al.  Enterocytes adhere preferentially to collagen IV in a differentially regulated divalent cation-dependent manner. , 1994, The American journal of physiology.

[7]  Frederick J. Schoen,et al.  Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves , 2000, Circulation.

[8]  W. Lougheed,et al.  Homologous Aortic-Valve-Segment Transplants as Surgical Treatment for Aortic and Mitral Insufficiency , 1956, Angiology.

[9]  W. Konertz,et al.  Is There a Possibility for a Glutaraldehyde-Free Porcine Heart Valve to Grow? , 2006, European Surgical Research.

[10]  K. Black,et al.  Recellularization of heart valve grafts by a process of adaptive remodeling. , 2001, Seminars in thoracic and cardiovascular surgery.

[11]  Wilson Ca,et al.  Porcine endogenous retroviruses and xenotransplantation. , 2008 .

[12]  K. Rådegran,et al.  In vitro endothelialization of commercially available heart valve bioprostheses with cultured adult human cells. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  Ernst Wolner,et al.  Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. , 2004, The Journal of thoracic and cardiovascular surgery.

[14]  F. Schoen,et al.  Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering , 2006, Circulation.

[15]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[16]  S. Smith,et al.  Allograft heart valve viability and valve-processing variables. , 1998, The Annals of thoracic surgery.

[17]  E Wolner,et al.  Comparison of Different Decellularization Procedures of Porcine Heart Valves , 2003, The International journal of artificial organs.

[18]  David P. Martin,et al.  Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. , 2000, Tissue engineering.

[19]  C. M. Agrawal,et al.  Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. , 2001, Journal of biomedical materials research.

[20]  E. Simpson.  Minor transplantation antigens: animal models for human host-versus-graft, graft-versus-host, and graft-versus-leukemia reactions. , 1998, Transplantation.

[21]  C K Breuer,et al.  Tissue engineering heart valves: valve leaflet replacement study in a lamb model. , 1995, The Annals of thoracic surgery.

[22]  L. Krishnan,et al.  Design of fibrin matrix composition to enhance endothelial cell growth and extracellular matrix deposition for in vitro tissue engineering. , 2009, Artificial organs.

[23]  A. Aguzzi,et al.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[24]  Tatsuo Nakamura.  コラーゲンスポンジで充填したポリグリコール酸(PGA)-コラーゲン神経導管を用いた末梢神経の再生 実験的研究とヒトへの応用 2)コラーゲンスポンジで充填したPGA-コラーゲン神経導管から成る神経導管の臨床応用 , 2003 .

[25]  K. A. Merendino,et al.  A clinical experience with the betapropiolactone-sterilized homologous aortic valve followed up to four years. , 1970, The Journal of thoracic and cardiovascular surgery.

[26]  P. Comoglio,et al.  Cell surface molecules and fibronectin-mediated cell adhesion: effect of proteolytic digestion of membrane proteins , 1982, The Journal of cell biology.

[27]  C K Breuer,et al.  Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. , 1996, Circulation.

[28]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[29]  T. Gulik-Krzywicki,et al.  Structural studies of the associations between biological membrane components. , 1975, Biochimica et biophysica acta.

[30]  Gustav Steinhoff,et al.  Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells , 1998, The Lancet.

[31]  P. Gratzer,et al.  Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. , 2005, Biomaterials.

[32]  M. Thubrikar,et al.  Stress sharing between the sinus and leaflets of canine aortic valve. , 1986, The Annals of thoracic surgery.

[33]  W. Konertz,et al.  Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. , 2007, The Annals of thoracic surgery.

[34]  P. Myerowitz,et al.  The fate of aortic valve homografts 12 to 17 years after implantation. , 1988, Chest.

[35]  Timothy M. Rose,et al.  Type C Retrovirus Released from Porcine Primary Peripheral Blood Mononuclear Cells Infects Human Cells , 1998, Journal of Virology.

[36]  A. G. Gittenberger-de Groot,et al.  Remodeling of the porcine pulmonary autograft wall in the aortic position. , 2000, The Journal of thoracic and cardiovascular surgery.

[37]  R. Klebe,et al.  Isolation of a collagen-dependent cell attachment factor , 1974, Nature.

[38]  W. Konertz,et al.  Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[39]  John Fisher,et al.  Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. , 2002, The Journal of heart valve disease.

[40]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[41]  K S Kunzelman,et al.  Mechanisms of aortic valve incompetence: finite element modeling of aortic root dilatation. , 2000, The Annals of thoracic surgery.

[42]  Axel Pruss,et al.  Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. , 2006, Tissue engineering.

[43]  W. Konertz,et al.  Endothelial cell-seeded bovine internal mammary artery for complete revascularization. , 2007, The Annals of thoracic surgery.

[44]  I. Fentie,et al.  Microscopic study of normal parietal pericardium and unimplanted Puig-Zerbini pericardial valvular heterografts. , 1984, The Journal of thoracic and cardiovascular surgery.

[45]  A Haverich,et al.  Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. , 2003, The Journal of thoracic and cardiovascular surgery.

[46]  Paul Curnow,et al.  Membrane proteins, lipids and detergents: not just a soap opera. , 2004, Biochimica et biophysica acta.

[47]  Keith Myers,et al.  Tubular heart valves: a new tissue prosthesis design--preclinical evaluation of the 3F aortic bioprosthesis. , 2005, The Journal of thoracic and cardiovascular surgery.

[48]  Mathias Wilhelmi,et al.  In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. , 2003, The Annals of thoracic surgery.

[49]  F J Schoen,et al.  Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. , 1998, The Journal of thoracic and cardiovascular surgery.

[50]  F. Bowman,et al.  Aortic valve replacement with frozen irradiated homografts. Long-term evaluation. , 1972, Circulation.

[51]  K J Halbhuber,et al.  Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. , 2003, Journal of structural biology.

[52]  F J Schoen,et al.  Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.